• By Concept
  • By Last Name
  • By Full Text

Iwatsubo, Takeshi

Grant Detail

The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.



Aging in the Brain-Role of the Fibrous Proteins

1 September 1985 - 30 April 2007
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,792,819

FY 2002
2R01AG006173-16
$ 409,886
FY 1989
5R01AG006173-05
$ 254,245
FY 1988
5R01AG006173-04
$ 290,775
FY 1987
5R01AG006173-03
$ 261,683
FY 1986
5R01AG006173-02
$ 270,336
FY 1985
1R01AG006173-01
$ 305,894
 
 
$ 1,792,819
Abstract

Intensive research by many laboratories, including work performed under this grant, has advanced the hypothesis that altered processing of the B-amyloid precursor protein (APP) or decreased clearance of its amyloid B-peptide (AB) fragment are critical pathogenic events in Alzheimer' s disease. Nevertheless, despite a wealth of reports about in vitro and in vivo activities of the precursor and its derivatives, the fundamental physiological function of APP has not been established. Based on recent studies in our and other laboratories and extensive preliminary data, we propose to elucidate systematically the function of APP and the molecular mechanism by which it accomplishes this function. The central hypothesis motivating this application is that the remarkably similar proteolytic processing of APP and the Notch receptors suggests that APP is itself a cell-surface receptor with a cognate ligand, the binding of which enables the release of the cytoplasmic domain (AICD) to the nucleus to activate specific genes. Based on substantial experience in APP processing and membrane protein biology obtained during the past 24 years of this grant, we will carry out 4 interrelated Aims: 1. to purify, identify and characterize a specific protein ligand(s) for the APP ectodomain; 2. to localize the APP intracellular domain (AICD) to the nucleus and study its stabilization and activites there; 3. to assess the phenotypic consequences, including for APP processing and intracellular AB generation, of signaling by the physiological ligand(s) in intact neurons; and 4. to establish the in vivo biochemical and electrophysiological effects of APP signaling in living animals. We will compare the ligand binding and potential signaling properties of APP to those of APLP-1 and APLP-2 and also explore whether APP processing and signaling alter those of Notch. Intriguing preliminary findings about AICD nuclear localization and stabilization by Fe65 and about transcriptional changes in the brains of APP knockout mice encourage us to pursue these aims. The results of the multifaceted experimental approach described herein should be revealing not only for the normal biology of APP but also for how its regulated signaling contributes to the pathogenesis of Alzheimer's disease and to the progressive accumulation of AB that accompanies normal brain aging in humans and other primates.

85 Resulting Publications

Scientific Context

This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.

Related Grants

Related Publications

Related Topics

Appears in this Publication



Related Experts

Author of this Publication

  • Internal Experts
    Publications